# Dermavizion — Mobile Categorised Dermatology

> Mobile Categorised Dermatology (iPhone/iPad app by SoftServe Investments (Pty) Ltd.)

- Source: https://appshunter.io/ios/app/dermavizion/id6746201306 (this page in markdown: same URL + `.md`)
- Developer: [SoftServe Investments (Pty) Ltd](https://appshunter.io/developer/1815719096)
- Category: Medical
- Price: Free
- Age rating: 12+
- Requires: iOS 14.0 · 14 MB
- Languages: English
- Released: 2025-06-26
- Data updated: 2026-10-28

## What is Dermavizion?

Dermavision is a clinical-grade dermatology imaging tool designed for professionals who need to document and monitor skin conditions over time. Using a full 3D body model, you can capture, tag, and categorise high-resolution skin images with anatomical accuracy.

Whether you're tracking moles, rashes, or lesions, DermaMap provides a streamlined interface for assigning images to precise body zones, allowing for clear documentation and longitudinal comparison.

Key Features:

Image capture linked to a dynamic 3D body

Organise and tag images by condition, patient, or visit

High-resolution camera support

Easy browsing of historical images per body region

Secure data handling built for clinical workflows

Ideal for dermatologists, skin cancer clinics, and aesthetic practitioners, DermaMap helps bring clarity and structure to visual skin assessments.

## Is Dermavizion safe?

Not enough ratings yet to assess Dermavizion.

## Is Dermavizion legit?

Dermavizion appears legitimate, with a few gaps. The AppsHunter Legitimacy Score for Dermavizion is 65 out of 100 points across 7 verification signals from App Store and developer data.


## Version history (last 3 releases)

### 1.15 — 2026-02-12

button labels
image zoom in feature

### 1.1 — 2025-06-30

bug fixes

### 1.0 — 2025-06-26

No release notes.

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-10-28.*